Terms: = Prostate cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
58 results:
1. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
2. Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.
Cui Y; Lin J; Sun D; Zhang H; Diao T; Fu Q
J Cancer Res Clin Oncol; 2024 Jan; 150(2):45. PubMed ID: 38281261
[TBL] [Abstract] [Full Text] [Related]
3. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: cancer detection rates and complication rates.
Hogenhout R; Remmers S; van Leenders GJLH; Roobol MJ
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):581-587. PubMed ID: 36631536
[TBL] [Abstract] [Full Text] [Related]
4. The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: Diagnostic accuracy of biopsy, MRI-visibility, and outcomes.
Pahouja G; Patel HD; Desai S; Rac G; Cheng T; Okabe Y; Gorbonos A; Quek ML; Flanigan RC; Picken MM; Gupta GN
Urol Oncol; 2023 Jan; 41(1):48.e11-48.e18. PubMed ID: 36441068
[TBL] [Abstract] [Full Text] [Related]
5. Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer.
Naito Y; Kato M; Kawanishi H; Yamamoto A; Sakamoto F; Hirabayashi H; Kobayashi M; Matsukawa Y; Kimura T; Araki H; Nishikimi T; Kondo A; Yoshino Y; Hashimoto Y; Nakano Y; Tsuzuki T
Prostate; 2023 Mar; 83(4):307-315. PubMed ID: 36420892
[TBL] [Abstract] [Full Text] [Related]
6. Cribriform Lesions of the prostate Gland.
Cai Q; Shah RB
Surg Pathol Clin; 2022 Dec; 15(4):591-608. PubMed ID: 36344177
[TBL] [Abstract] [Full Text] [Related]
7. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Kench JG; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Moch H; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tsuzuki T; Turjalic S; van der Kwast TH; Zhou M; Srigley JR
Histopathology; 2022 Oct; 81(4):447-458. PubMed ID: 35758185
[TBL] [Abstract] [Full Text] [Related]
8. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract] [Full Text] [Related]
9. Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.
Plante A; Dallaire F; Grosset AA; Nguyen T; Birlea M; Wong J; Daoust F; Roy N; Kougioumoutzakis A; Azzi F; Aubertin K; Kadoury S; Latour M; Albadine R; Prendeville S; Boutros P; Fraser M; Bristow RG; van der Kwast T; Orain M; Brisson H; Benzerdjeb N; Hovington H; Bergeron A; Fradet Y; Têtu B; Saad F; Trudel D; Leblond F
J Biomed Opt; 2021 Nov; 26(11):. PubMed ID: 34743445
[TBL] [Abstract] [Full Text] [Related]
10. CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia.
Offermann A; Joerg V; Hupe MC; Becker F; Müller M; Brägelmann J; Kirfel J; Merseburger AS; Sailer V; Tharun L; Perner S
Hum Pathol; 2021 Nov; 117():60-67. PubMed ID: 34314763
[TBL] [Abstract] [Full Text] [Related]
11. Current Understanding and Management of Intraductal Carcinoma of the prostate.
Considine B; Adeniran A; Hurwitz ME
Curr Oncol Rep; 2021 Jul; 23(9):110. PubMed ID: 34272624
[TBL] [Abstract] [Full Text] [Related]
12. Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM; Fumadó-Ciutat L; Gasa-Galmes B; Costa-Planells M; Munarriz-Polo M; Sanromà-Salvà A; Polaina-Barroso L; Solà-Marqués C; Juanpere-Rodero N; Lloreta-Trull J; Cecchini-Rosell L
Actas Urol Esp (Engl Ed); 2021; 45(6):455-460. PubMed ID: 34147428
[TBL] [Abstract] [Full Text] [Related]
13. Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato M; Hirakawa A; Sato H; Hanazawa R; Naito Y; Tochigi K; Sano T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Hattori R; Tsuzuki T
Int J Clin Oncol; 2021 Apr; 26(4):764-769. PubMed ID: 33385274
[TBL] [Abstract] [Full Text] [Related]
14. Intraductal Carcinoma of the prostate: Pathogenesis and Molecular Perspectives.
Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
[TBL] [Abstract] [Full Text] [Related]
15. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.
Grosset AA; Dallaire F; Nguyen T; Birlea M; Wong J; Daoust F; Roy N; Kougioumoutzakis A; Azzi F; Aubertin K; Kadoury S; Latour M; Albadine R; Prendeville S; Boutros P; Fraser M; Bristow RG; van der Kwast T; Orain M; Brisson H; Benzerdjeb N; Hovington H; Bergeron A; Fradet Y; Têtu B; Saad F; Leblond F; Trudel D
PLoS Med; 2020 Aug; 17(8):e1003281. PubMed ID: 32797086
[TBL] [Abstract] [Full Text] [Related]
16. Effect of core needle biopsy number on intraductal carcinoma of the prostate (idc-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Naito Y; Tochigi K; Sano T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Hattori R; Tsuzuki T
Int J Clin Oncol; 2020 Dec; 25(12):2130-2137. PubMed ID: 32748295
[TBL] [Abstract] [Full Text] [Related]
17. [Epidemiology of prostate cancer (PCa) in French Guyana (FG) - Preliminary results].
Tean O; Bras Da Silva C; Vega Toro P; Barre P; Molinie V; Ravery V
Prog Urol; 2020; 30(8-9):456-462. PubMed ID: 32493660
[TBL] [Abstract] [Full Text] [Related]
18. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
[TBL] [Abstract] [Full Text] [Related]
19. Influence of sociodemographic factors on treatment's choice for localized prostate cancer in Portugal.
Pereira-Lourenço M; Vieira E Brito D; Peralta JP; Godinho R; Conceiçao P; Reis M; Rabaça C; Sismeiro A
Arch Ital Urol Androl; 2020 Apr; 92(1):45-49. PubMed ID: 32255317
[TBL] [Abstract] [Full Text] [Related]
20. Intraductal carcinoma of the prostate.
Szentirmai E; Giannico GA
Pathologica; 2020 Mar; 112(1):17-24. PubMed ID: 32202536
[TBL] [Abstract] [Full Text] [Related]
[Next]
